Challenges in the recruitment of adolescents and young adults to cancer clinical trials.

Abstract:

:The adolescent and young adult (AYA) oncology population has seen inferior progress in cancer survival compared with younger children and older adults over the past 25 years. Previously, AYAs had the best survival rates due to the prevalence of highly curable diseases including Hodgkin lymphoma and germ cell tumors, yet today AYAs have inferior survival rates to children and some adult cohorts. Survival rates are particularly poor for AYA-specific diseases such as sarcomas. Research involving children and adults diagnosed with common malignancies such as acute lymphoblastic leukemia has resulted in improved survival rates. However, AYAs have not directly benefited from such research due to low rates of access to and accrual on clinical trials. AYAs are less likely to have insurance or access to healthcare, are more likely to see providers who are not part of research institutions, and are less likely to be referred to or to join clinical trials, all of which may contribute to worse outcomes. Few clinical trials target AYA-specific diseases, leading to little information regarding how these diseases behave and what role the host plays. Tumor samples for this population are underrepresented in national tumor banks. Coupled with the need for more clinical trials that focus on AYA-specific cancers, better collaboration between adult and pediatric cooperative groups as well as increased education among community oncologists and primary care providers will be needed to enhance participation in clinical trials with the goal to increase survival and improve quality of that survival.

journal_name

Cancer

journal_title

Cancer

authors

Burke ME,Albritton K,Marina N

doi

10.1002/cncr.23060

subject

Has Abstract

pub_date

2007-12-01 00:00:00

pages

2385-93

issue

11

eissn

0008-543X

issn

1097-0142

journal_volume

110

pub_type

杂志文章,评审

相关文献

CANCER文献大全
  • Risk factors for infections with multidrug-resistant Stenotrophomonas maltophilia in patients with cancer.

    abstract:BACKGROUND:Stenotrophomonas maltophilia is responsible for an increasing number of infections, especially in hospitalized patients. Therapy options are limited and trimethoprim/sulfamethoxazole (TMP/SMX) is often the main treatment option for this infection. In the current study, the risk factors were determined for th...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.22705

    authors: Ansari SR,Hanna H,Hachem R,Jiang Y,Rolston K,Raad I

    更新日期:2007-06-15 00:00:00

  • Adjuvant therapy of osteosarcoma--A Phase II trial: Southwest Oncology Group study 9139.

    abstract:BACKGROUND:The objective of this study was to estimate the time to treatment failure and survival rate of the three-drug combination of doxorubicin, cisplatin, and ifosfamide as primary and postoperative, adjunctive treatment for teenagers and adults with osteosarcoma (OS). METHODS:Sixty-three eligible patients with n...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1002/cncr.20021

    authors: Zalupski MM,Rankin C,Ryan JR,Lucas DR,Muler J,Lanier KS,Budd GT,Biermann JS,Meyers FJ,Antman K

    更新日期:2004-02-15 00:00:00

  • Genetic predisposition to breast cancer.

    abstract::Breast cancer is the most common cancer among American women. Because metastatic breast cancer is an incurable disease, efforts to decrease breast cancer mortality have focused on early detection and improved treatment. Identification and analysis of a specific genetic susceptibility could permit detection of suscepti...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:10.1002/1097-0142(19920915)70:4+<1747::aid-cncr282

    authors: Skolnick MH,Cannon-Albright LA

    更新日期:1992-09-15 00:00:00

  • Transgenic models for the study of prostate cancer.

    abstract::Transgenic model systems provide tools for obtaining information that clarifies important relationships between genetic alterations and carcinogenesis. One such relationship is the induction of specific growth factor activities by dominantly acting oncogenes. Using a "transgenic organ" model referred to as mouse prost...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:10.1002/1097-0142(19930201)71:3+<1165::aid-cncr282

    authors: Thompson TC,Truong LD,Timme TL,Kadmon D,McCune BK,Flanders KC,Scardino PT,Park SH

    更新日期:1993-02-01 00:00:00

  • Hiccups with high dose dexamethasone administration: a case report.

    abstract:BACKGROUND:A 59-year-old male developed intractable hiccups during monthly therapy with high dose dexamethasone for multiple myeloma. Hiccups would begin hours after his first dose and continue over the 4 days of therapy. He sought assistance after his attempt at home remedies failed and the hiccups became exhausting. ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/(sici)1097-0142(19980115)82:2<415::aid-cnc

    authors: Cersosimo RJ,Brophy MT

    更新日期:1998-01-15 00:00:00

  • A scanning electron microscopy study of changes in the colonic mucus layer during chemical carcinogenesis.

    abstract::Scanning electron microscopy was used to examine the appearances of the colonic mucus layer of rats during chemical carcinogenesis with dimethylhydrazine. The normal colonic mucus layer had a dense homogeneous appearance and provided a complete cover for the mucosal epithelium. At high magnifications tiny fenestration...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19830515)51:10<1847::aid-cncr282

    authors: Traynor OJ,Costa NL,Wood CB

    更新日期:1983-05-15 00:00:00

  • Non-Hodgkin's lymphoma of the larynx (stage IE).

    abstract::Four cases of non-Hodgkin's lymphoma (NHL) limited to the larynx are described. All were diffuse, high-grade, B-cell lymphomas of large lymphoid cell type (three centroblastic and one immunoblastic). Immunocytochemistry was performed on three cases; two showed monoclonal cytoplasmic immunoglobulin and one showed monoc...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19890901)64:5<1123::aid-cncr2820

    authors: Morgan K,MacLennan KA,Narula A,Bradley PJ,Morgan DA

    更新日期:1989-09-01 00:00:00

  • Early hypofractionated salvage radiotherapy for postprostatectomy biochemical recurrence.

    abstract:BACKGROUND:Postprostatectomy adjuvant or salvage radiotherapy, when using standard fractionation, requires 6.5 to 8 weeks of treatment. The authors report on the safety and efficacy of an expedited radiotherapy course for salvage prostate radiotherapy. METHODS:A total of 108 consecutive patients were treated with salv...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.25824

    authors: Kruser TJ,Jarrard DF,Graf AK,Hedican SP,Paolone DR,Wegenke JD,Liu G,Geye HM,Ritter MA

    更新日期:2011-06-15 00:00:00

  • The frequency of a concomitant early esophageal cancer in male patients with oral and oropharyngeal cancer. Screening results using Lugol dye endoscopy.

    abstract:BACKGROUND:Male patients with oral and oropharyngeal cancer are known to have high risk of concomitant esophageal cancer developing. Thus, mass screening programs are pursued to detect such esophageal cancer early, and in a mass screening trial of patients with early oral and oropharyngeal cancer, the efficacy of Lugol...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章

    doi:10.1002/1097-0142(19940415)73:8<2038::aid-cncr2820

    authors: Ina H,Shibuya H,Ohashi I,Kitagawa M

    更新日期:1994-04-15 00:00:00

  • The significance of urokinase- type plasminogen activator, its inhibitors, and its receptor in ascites of patients with epithelial ovarian cancer.

    abstract:BACKGROUND:Strong correlations have been reported between expression of urokinase-type plasminogen activator (uPA) and poor prognosis in several human carcinomas. The clinical significance of secreted levels of uPA, its receptor (uPAR), and its inhibitors (PAI-1 and PAI-2) in the ascites of patients with epithelial ova...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19950401)75:7<1627::aid-cncr2820

    authors: Chambers SK,Gertz RE Jr,Ivins CM,Kacinski BM

    更新日期:1995-04-01 00:00:00

  • Association of the highly prevalent TP53 R337H mutation with pediatric choroid plexus carcinoma and osteosarcoma in southeast Brazil.

    abstract:BACKGROUND:The inherited, low-penetrance arginine-to-histidine substitution at codon 337 (R337H) of the tumor protein 53 gene (TP53) is clustered in southeast Brazil (estimated frequency, 0.3%). Although its tumorigenic effect initially appeared to be tissue-specific, recent evidence suggests its association with a bro...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.25826

    authors: Seidinger AL,Mastellaro MJ,Paschoal Fortes F,Godoy Assumpção J,Aparecida Cardinalli I,Aparecida Ganazza M,Correa Ribeiro R,Brandalise SR,Dos Santos Aguiar S,Yunes JA

    更新日期:2011-05-15 00:00:00

  • The use of serial CEA determinations to predict recurrence of colon cancer and when to do a second-look operation.

    abstract::The concept of second-look surgery was introduced by Wangensteen 25 years ago, and 17% of patients were reported to be converted to a cancer-free state. Instead of an arbitrary time interval for reoperation, serial CEA values were used as the indicator of colon cancer recurrence and second-look operation. Twenty-two r...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197809)42:3+<1422::aid-cncr28204

    authors: Minton JP,Martin EW Jr

    更新日期:1978-09-01 00:00:00

  • P-glycoprotein expression in canine lymphoma: a relevant, intermediate model of multidrug resistance.

    abstract:BACKGROUND:Despite extensive investigation, the role of MDR of human cancer remains unclear. Canine lymphoma is a spontaneously arising correlate of human non-Hodgkin's lymphoma that may complement other in vivo models for investigation of issues related to MDR. METHODS:Immunoreactivity of primary antibodies to the hu...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/(SICI)1097-0142(19960501)77:9<1892::AID-CN

    authors: Lee JJ,Hughes CS,Fine RL,Page RL

    更新日期:1996-05-01 00:00:00

  • Quality of care received and patient-reported regret in prostate cancer: Analysis of a population-based prospective cohort.

    abstract:BACKGROUND:Meeting quality of care standards in oncology is recognized as important by physicians, professional organizations, and payers. Data from a population-based cohort of patients with prostate cancer were used to examine whether receipt of care was consistent with published consensus metrics and whether receivi...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.30315

    authors: Holmes JA,Bensen JT,Mohler JL,Song L,Mishel MH,Chen RC

    更新日期:2017-01-01 00:00:00

  • The impact of cancer on spouses' labor earnings: a population-based study.

    abstract:BACKGROUND:Cancer affects patients' incomes, but to the authors' knowledge few studies to date have examined how the income of the patients' spouses may be influenced. In this population-based study from Norway, the effects of cancer on both partners' earnings are analyzed. METHODS:The difference between labor earning...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.24582

    authors: Syse A,Tretli S,Kravdal O

    更新日期:2009-09-15 00:00:00

  • Treatment of advanced thyroid cancer with axitinib: Phase 2 study with pharmacokinetic/pharmacodynamic and quality-of-life assessments.

    abstract:BACKGROUND:In a previous phase 2 trial, axitinib was active and well tolerated in patients with advanced thyroid cancer. In this second phase 2 trial, the efficacy and safety of axitinib were evaluated further in this population, and pharmacokinetic/pharmacodynamic relationships and patient-reported outcomes were asses...

    journal_title:Cancer

    pub_type: 杂志文章,多中心研究

    doi:10.1002/cncr.28766

    authors: Locati LD,Licitra L,Agate L,Ou SH,Boucher A,Jarzab B,Qin S,Kane MA,Wirth LJ,Chen C,Kim S,Ingrosso A,Pithavala YK,Bycott P,Cohen EE

    更新日期:2014-09-01 00:00:00

  • Heterogeneity among the non-Hodgkin's lymphomas. Implications for autologous bone marrow transplantation with in vitro purging using monoclonal antibodies.

    abstract::To investigate the possible implications of heterogeneity among the non-Hodgkin's lymphomas for bone marrow purging using complement-fixing monoclonal antibodies to lymphoma-associated antigens, a panel of large cell lymphoma cell lines of diverse phenotypes was treated with monoclonal antibodies DLC-48 and LN-1. An a...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19880315)61:6<1082::aid-cncr2820

    authors: Winter JN,Marder RJ,Mankad B,Epstein AL

    更新日期:1988-03-15 00:00:00

  • Sinusoidal hematolymphoid malignancy ("malignant histiocytosis") presenting as atypical sinusoidal proliferation. A study of nine cases.

    abstract::A number of cases of sinusoidal hematolymphoid malignancy ("malignant histiocytosis") in which early lymph node biopsies have not allowed clear separation from benign histiocytic disorders have been observed. Nine such cases in which only a follow-up lymph node biopsy documented their malignant nature are reported. Se...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19861015)58:8<1681::aid-cncr2820

    authors: Weiss LM,Azzi R,Dorfman RF,Warnke RA

    更新日期:1986-10-15 00:00:00

  • Phase 1/2 study of DFP-10917 administered by continuous intravenous infusion in patients with recurrent or refractory acute myeloid leukemia.

    abstract:BACKGROUND:DFP-10917, a deoxycytidine nucleoside analogue, has a unique mechanism of action resulting in leukemic cell death when administered for prolonged periods at low doses. The current phase 1/2 study investigated the safety, maximum tolerated dose, and evidence of antileukemic activity for DFP-10917 administered...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.31923

    authors: Kantarjian HM,Jabbour EJ,Garcia-Manero G,Kadia TM,DiNardo CD,Daver NG,Borthakur G,Jain N,Waukau JB,Kwari MI,Ravandi F,Anderson BD,Iizuka K,Jin C,Zhang C,Plunkett WK

    更新日期:2019-05-15 00:00:00

  • Pelvic and ovarian extramedullary leukemic relapse in young girls: a report of four cases and review of the literature.

    abstract::Currently attention is focused on the testicle as a site of leukemic relapse. Leukemic involvement of the ovary has been described in several autopsy series with an incidence of 11-50% in patients with bone marrow relapse, but has rarely been reported during the clinical course of leukemia. In this report, four girls ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19820801)50:3<587::aid-cncr28205

    authors: Cecalupo AJ,Frankel LS,Sullivan MP

    更新日期:1982-08-01 00:00:00

  • Oxaliplatin and capecitabine in the treatment of patients with recurrent or refractory carcinoma of unknown primary site: a phase 2 trial of the Sarah Cannon Oncology Research Consortium.

    abstract:BACKGROUND:Despite the widespread use of oxaliplatin-based regimens for colorectal and other gastrointestinal cancers, there is surprisingly little information regarding their empiric use for the treatment of carcinoma of unknown primary site (CUP). In the current study, the combination of oxaliplatin and capecitabine ...

    journal_title:Cancer

    pub_type: 杂志文章,多中心研究

    doi:10.1002/cncr.25029

    authors: Hainsworth JD,Spigel DR,Burris HA 3rd,Shipley D,Farley C,Macias-Perez IM,Barton J,Greco FA

    更新日期:2010-05-15 00:00:00

  • PEG-IFN-alpha-2b therapy in BCR-ABL-negative myeloproliferative disorders: final result of a phase 2 study.

    abstract:BACKGROUND:Interferon-alpha (IFN-alpha) has shown significant activity in the treatment of BCR-ABL-negative myeloproliferative disorders (MPDs), particularly essential thrombocythemia (ET) and polycythemia vera (PV). PEG-IFN-alpha-2b is a pegylated IFN-alpha-2b with a significant advantage over nonpegylated form in tha...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.23018

    authors: Jabbour E,Kantarjian H,Cortes J,Thomas D,Garcia-Manero G,Ferrajoli A,Faderl S,Richie MA,Beran M,Giles F,Verstovsek S

    更新日期:2007-11-01 00:00:00

  • Long-term treatment results of postoperative radiation therapy for advanced stage oropharyngeal carcinoma.

    abstract:BACKGROUND:The authors report the long-term treatment results for advanced stage base of tongue (BOT) and tonsillar fossa (TF) carcinomas treated with surgery and postoperative radiation therapy (RT) at Memorial Sloan-Kettering Cancer Center. METHODS:Between 1973 and 1986, 51 patients with squamous cell carcinoma of t...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19921115)70:10<2388::aid-cncr282

    authors: Zelefsky MJ,Harrison LB,Armstrong JG

    更新日期:1992-11-15 00:00:00

  • Prognostic and therapeutic use of microstaging of cutaneous squamous cell carcinoma of the trunk and extremities.

    abstract::Cutaneous squamous cell carcinomas (SCC) arising in actinically damaged skin, unassociated with chronic inflammation or injury, are generally regarded as nonaggressive lesions. These tumors occasionally recur or metastasize, however, as do de novo SCC. The authors reviewed 63 patients with cutaneous SCC of the trunk o...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19850901)56:5<1099::aid-cncr2820

    authors: Friedman HI,Cooper PH,Wanebo HJ

    更新日期:1985-09-01 00:00:00

  • Lymphokines, monoclonal antibodies, and other biological response modifiers in the treatment of cancer.

    abstract::Biologicals and biological response modifiers (BRMs) represent a new class of agents for cancer therapy. Historically, there have been many attempts to stimulate the immune response with nonspecific immunomodulators in the form of bacterial extracts, viruses, and chemicals. Although these approaches have occasionally ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19841201)54:2+<2795::aid-cncr282

    authors: Oldham RK,Thurman GB,Talmadge JE,Stevenson HC,Foon KA

    更新日期:1984-12-01 00:00:00

  • Improved accuracy in differentiating malignant from benign mammographic abnormalities: a simple, improved magnetic resonance imaging method.

    abstract:BACKGROUND:Although several refinements have been reported for breast magnetic resonance imaging (MRI), there has been no uniform agreement by researchers on the optimal method. The authors report a simple and effective MRI method that incorporated the best qualities of other breast MRI methods yet eliminated the compl...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(20010801)92:3<471::aid-cncr1345>

    authors: Khatri VP,Stuppino JJ,Espinosa MH,Pollack MS

    更新日期:2001-08-01 00:00:00

  • Hidden barriers between knowledge and behavior: the North Carolina prostate cancer screening and treatment experience.

    abstract:BACKGROUND:Prostate cancer (PC) mortality is much greater for African American than for Caucasian men. To identify patient factors that might account for some of this disparity, men within 6 months of diagnosis were surveyed about health attitudes and behavior. METHODS:Using Rapid Identification in the North Carolina ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.22583

    authors: Talcott JA,Spain P,Clark JA,Carpenter WR,Do YK,Hamilton RJ,Galanko JA,Jackman A,Godley PA

    更新日期:2007-04-15 00:00:00

  • Hereditary diffuse gastric cancer: diagnosis, genetic counseling, and prophylactic total gastrectomy.

    abstract:BACKGROUND:A subset of patients with diffuse gastric cancer harbor deleterious cancer-causing germline mutations in the type 1 E-cadherin (epithelial) gene (CDH1), which predisposes to the autosomal dominantly inherited hereditary diffuse gastric cancer (HDGC) syndrome. These mutations are associated with a 70% life-ti...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.23501

    authors: Lynch HT,Kaurah P,Wirtzfeld D,Rubinstein WS,Weissman S,Lynch JF,Grady W,Wiyrick S,Senz J,Huntsman DG

    更新日期:2008-06-15 00:00:00

  • Colorectal carcinoma cell production of transforming growth factor beta decreases expression of endothelial cell vascular endothelial growth factor receptor 2.

    abstract:BACKGROUND:Vascular endothelial growth factor (VEGF) signaling is a target for antiangiogenic cancer therapy. The authors have previously observed that up to 40% of vessels in colorectal carcinoma (CRC) tumors are negative for VEGF receptor 2 (VEGFR2) expression. Differential activity of transforming growth factor beta...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.26247

    authors: Kuczynski EA,Viloria-Petit AM,Coomber BL

    更新日期:2011-12-15 00:00:00

  • Anti-HTLV-1 antibody positive cutaneous T-cell lymphoma.

    abstract:BACKGROUND:Adult T-cell leukemia/lymphoma (ATLL) is a neoplasm of the mature helper T-lymphocyte. Human T-lymphotropic virus type 1 (HTLV-1) has been shown to be the cause of this neoplasm. Recently, however, the HTLV-1 genome has been found in some patients with cutaneous T-cell lymphoma (CTCL), which suggests a causa...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:

    authors: Kikuchi A,Ohata Y,Matsumoto H,Sugiura M,Nishikawa T

    更新日期:1997-01-15 00:00:00